FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 09/2021”.
The Monitor is a month-to-month revealed overview of enterprise capital tendencies within the European Life Sciences sector.
As of the top of September 2021 we establish the next present VC tendencies in Europe:
- In 2021, general Life Sciences funding has reached EUR 9,955m to date
- Prime 5 Offers exceed EUR 190m every, largest transaction amounted to EUR 497m in CMR Surgical Ltd. (United Kingdom)
- BlackRock (USA) nonetheless dominates the Prime 5 Traders (by deal quantity), adopted by Constancy Administration & Analysis (USA) and Novo Holdings (Denmark)
- The Biotechnology sector acquired 43% of the overall funding quantity (-7% factors in comparison with the earlier month)
- Oncology dominates as the highest indication
To entry the total report, please click on right here.
By Dr. Mathias Schott, Sebastian Sommer and Alexander Kuhn